BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, July 30, 2026
Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 3, 2004

View Archived Issues

ProStrakan Raises £22M Privately, Now Waits For Chance At UK IPO

LONDON - ProStrakan Group Ltd. raised £22 million (US$40.3 million) from existing shareholders, giving it the leeway to launch an initial public offering at the time of its choosing in 2005 and enabling former Strakan institutional investors to recalibrate their shareholdings following the merger earlier this year with ProSkelia SA. (BioWorld International) Read More

Conference Speaker: Investors Lack Faith In European Biotech

Read More

Hopes Rise For Therapeutic Approach To Prostate Cancer

Read More

Symphogen Raises DKK155M For Polyclonal Antibody Work

Read More

New Biotech Super-Cluster In France Announced At Meeting

Read More

Basilea Moves BAL4079 To Phase III In Hand Dermatitis

Read More

Low Sales, Losses Cause Massive Layoffs At MWG

Read More

Narhex Seeks A$8M IPO To Develop HIV Drug In China

Read More

Paratek, Serono In $38M-Plus Collaboration For MS Drugs

Read More

Other News To Note

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 28, 2026
  • Illustration of dopamine signaling in the brain

    New schizophrenia targets challenge trial design

    BioWorld
    The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
  • Regulatory actions for July 27, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
  • 3D representation of tumor

    AACR D3: ONM-421 shows antigen-independent tumor control

    BioWorld Science
    At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing